Discover a new way to find and share stories you'll love… Learn about Reading Desk

Post Profile



Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy

CAMBRIDGE, Mass. (May 22, 2012) – Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part of this system, heat shock protein 90 (HSP90) has been shown to help malignant cells accommodate the genetic changes and profound disturbances in normal biology that occur in cancers.
read more

share

VCU Massey Cancer Center Receives $4.4 Million NCI Grant to Support a Statewide Cancer Clinical Trials Network, Foster Minority Access to Trials and Focus Research on Cancer Disparities

Health : Newswise Medical News (yesterday)

VCU Massey Cancer Center was awarded a $4.4 million, 5-year, renewable grant from the National Cancer Institute to support a statewide network for cancer clinical research in Virginia that brings state-of-the-art clinical trials to ... Read Post

Breast Cancer Clinical Trial to Test Combination of Heat Shock Protein Inhibitor and Hormonal Therapy

Health : Newswise Medical News (2 years ago)

A clinical trial involving collaboration between researchers at Whitehead Institute and Dana Farber Cancer Institute is now enrolling patients with recurrent or metastatic estrogen receptor-positive (ER+) breast cancer. The trial wi... Read Post

Combo Of Heat Shock Protein Inhibitor And Hormonal Therapy Being Tested In Breast Cancer Clinical Trial

Health : Medical News Today (2 years ago)

Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part of this... Read Post


Copyright © 2011 Regator, LLC